Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Motor Activity 1Advanced Solid Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × mitazalimab × Clear all
NCT05650918 2023-10-12

REACtiVe-2

Erasmus Medical Center

Phase 1 Completed
22 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02829099 2022-10-06

A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors

Janssen Research & Development, LLC

Phase 1 Completed
95 enrolled

Advanced Solid Neoplasms

NCT02379741 2017-03-27

ADC-1013 First-in-Human Study

Alligator Bioscience AB

Phase 1 Completed
24 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡